Table of Contents
Chapter 1. Global Carrier Screening Market Executive Summary
1.1. Global Carrier Screening Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Technology
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Carrier Screening Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Carrier Screening Market Dynamics
3.1. Market Drivers
3.1.1. Rising Awareness and Demand for Genetic Testing
3.1.2. Technological Advancements
3.2. Market Challenges
3.2.1. Ethical and Privacy Concerns
3.3. Market Opportunities
3.3.1. Emerging Markets
3.3.2. Integration with Personalized Medicine
Chapter 4. Global Carrier Screening Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Carrier Screening Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Carrier Screening Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Expanded Carrier Screening
5.2.2. Targeted Disease Carrier Screening
Chapter 6. Global Carrier Screening Market Size & Forecasts by Technology 2022-2032
6.1. Segment Dashboard
6.2. Global Carrier Screening Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. DNA Sequencing
6.2.2. Polymerase Chain Reaction
6.2.3. Microarrays
6.2.4. Others
Chapter 7. Global Carrier Screening Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Carrier Screening Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals and Clinics
7.2.2. Reference Laboratories
7.2.3. Physician Offices
7.2.4. Others
Chapter 8. Global Carrier Screening Market Size & Forecasts by Region 2022-2032
8.1. North America Carrier Screening Market
8.1.1. U.S. Carrier Screening Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Technology breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Carrier Screening Market
8.2. Europe Carrier Screening Market
8.2.1. U.K. Carrier Screening Market
8.2.2. Germany Carrier Screening Market
8.2.3. France Carrier Screening Market
8.2.4. Spain Carrier Screening Market
8.2.5. Italy Carrier Screening Market
8.2.6. Rest of Europe Carrier Screening Market
8.3. Asia-Pacific Carrier Screening Market
8.3.1. China Carrier Screening Market
8.3.2. India Carrier Screening Market
8.3.3. Japan Carrier Screening Market
8.3.4. Australia Carrier Screening Market
8.3.5. South Korea Carrier Screening Market
8.3.6. Rest of Asia Pacific Carrier Screening Market
8.4. Latin America Carrier Screening Market
8.4.1. Brazil Carrier Screening Market
8.4.2. Mexico Carrier Screening Market
8.4.3. Rest of Latin America Carrier Screening Market
8.5. Middle East & Africa Carrier Screening Market
8.5.1. Saudi Arabia Carrier Screening Market
8.5.2. South Africa Carrier Screening Market
8.5.3. Rest of Middle East & Africa Carrier Screening Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Natera Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Eurofins Scientific
9.3.3. InVitae Corporation
9.3.4. Illumina Inc.
9.3.5. Myriad Genetics, Inc.
9.3.6. Thermo Fisher Scientific Inc.
9.3.7. Fulgent Genetics Inc.
9.3.8. Quest Diagnostics Inc.
9.3.9. Diasorin S.p.A.
9.3.10. Opko Health Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes